La cadena de opciones muestra datos clave de las opciones de acciones de UTime a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para UTime..

UTime (NASDAQ:WTO) Bolsa, Cadena de Opciones

UTime

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; and Do, as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

UTime Ltd

Lake Street analyst Frank Takkinen initiates coverage on Axogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXGN#NASDAQ">AXGN</a>) with a Buy rating and announces Price Target of $30.

News

Price Target

Initiation

Analyst Ratings

AXGN

Lake Street Initiates Coverage On Axogen with Buy Rating, Announces Price Target of $30

Lake Street analyst Ryan Meyers initiates coverage on FitLife Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTLF#NASDAQ">FTLF</a>) with a Buy rating and announces Price Target of $21.

FTLF

Lake Street Initiates Coverage On FitLife Brands with Buy Rating, Announces Price Target of $21

<ul>
<li>Results from Phase 2 RAINFOLTM-01 trial (B1 cohort) showed that with a median on-study follow-up of 48 weeks, Rina-S 120 mg/m2 led to a confirmed objective response rate (ORR) of 55.6% and median duration of response (mDOR) was not reached</li>
<li>Phase 2 RAINFOLTM-01 and Phase 3 RAINFOLTM-02 trials evaluating the safety and efficacy of Rina-S at 120 mg/m2 in patients with platinum resistant ovarian cancer (PROC) are actively recruiting</li>
</ul>
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.genmab.com&amp;esheet=54224797&amp;newsitemid=20250317671140&amp;lan=en-US&amp;anchor=Genmab+A%2FS&amp;index=1&amp;md5=937fd94e30877dd202724d690e217580">Genmab A/S</a> (NASDAQ:<a href="https://www.benzinga.com/stock/GMAB#NASDAQ">GMAB</a>) announced today updated data from cohort B1 of the Phase 1/2 RAINFOL-01 study of rinatabart sesutecan (Rina-S&#xAE;), an investigational folate receptor-alpha (FRα)-targeted, TOPO1 antibody-drug conjugate (ADC) that showed Rina-S 120 mg/m2 every 3 weeks (Q3W) resulted in a confirmed objective response rate (ORR) of 55.6% (95% CI: 30.8-78.5) in heavily pre-treated ovarian cancer (OC) patients regardless of FRα expression levels. With a median on-study follow-up of 48 weeks, 1 out of 10 patients experienced disease progression and the median duration of response (mDOR) was not reached (95% CI: 40.14-NR). The data are from the dose expansion cohort of the multi-part study evaluating the safety and efficacy of Rina-S as a single agent in solid tumors that are known to express FRα and were presented at the 2025 Society of Gynecologic Oncology Annual Meeting on Women's Cancer&#xAE; (SGO) in Seattle, Washington.

Biotech

General

GMAB

Genmab Announces Updated Data From Cohort B1 Of The Phase 1/2 RAINFOL-01 Study Of Rinatabart Sesutecan; Showed That With A Median On-Study Follow-Up Of 48 Weeks, Led To A Confirmed Objective Response Rate Of 55.6% And Median Duration Of Response Was Not Reached

Piper Sandler analyst Allison Bratzel maintains Ultragenyx Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RARE#NASDAQ">RARE</a>) with a Overweight and lowers the price target from $140 to $115.

RARE

Piper Sandler Maintains Overweight on Ultragenyx Pharmaceutical, Lowers Price Target to $115

Scholar Rock Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRRK#NASDAQ">SRRK</a>) said on Sunday the company will present new efficacy and safety data from the Phase 3 pivotal SAPPHIRE trial at the 2025 Muscular Dystrophy Association (MDA) <a href="https://www.benzinga.com/general/biotech" target="_blank" rel="noreferrer noopener">Clinical &amp; Scientific Conference</a>.
The Phase 3 SAPPHIRE trial evaluated the efficacy and safety of apitegromab, an investigational muscle-targeted therapy being developed to provide clinically meaningful improvement in motor function for people living with spinal muscular atrophy (SMA) who are <a href="https://www.benzinga.com/pressreleases/25/03/b44348561/scholar-rock-presents-new-phase-3-sapphire-data-at-the-2025-muscular-dystrophy-association-clinica" target="_blank" rel="noreferrer noopener">receiving SMN-targeted treatments</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/43013242/scholar-rock-sets-sights-on-2-billion-apitegromab-revenue-amid-spinal-muscular-atrophy-market-growth" rel="noreferrer noopener">Scholar Rock Sets Sights on $2 Billion Apitegromab Revenue Amid Spinal Muscular Atrophy Market Growth</a>
The topline data released in October 2024 showed the study achieved its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in motor function for apitegromab versus placebo in SMA patients on chronic dosing of <a href="https://www.benzinga.com/general/biotech/24/10/41208885/scholar-rocks-muscle-wasting-drug-excels-in-pivotal-trial-plans-fda-submission-next-year" target="_blank" rel="noreferrer noopener">standard-of-care therapies</a>.
New analysis performed in the pooled population (ages 2-21) showed clinically meaningful and consistent improvement in HFMSE across pre-specified subgroups (type of SMN-targeted therapy, age at SMN-targeted therapy initiation) and geographic region.
For secondary endpoints measured on patients ages 2-12 receiving apitegromab (10 mg/kg and 20 mg/kg) or placebo, the following improvements were observed:
<ul>
<li>A greater proportion of patients treated with apitegromab had improvements of ≥3 points in their HFMSE scores compared to placebo with odds ratio of 3.0 (nominal&nbsp;p-value&nbsp;= 0.0256).</li>
<li>Additionally, 30.4% of patients receiving apitegromab had ≥ 3-point improvement in HFMSE versus 12.5% of patients on placebo (nominal p-value= 0.0156).</li>
<li>Consistent improvement in motor function with a greater proportion of participants on apitegromab achieving HFMSE improvements versus placebo across all five-point thresholds at 52 weeks.</li>
</ul>
Treatment with apitegromab was well-tolerated across all age groups, consistent with the established safety profile and with no clinically relevant differences by dose.
SRRK Price Action: Scholar Rock Holding stock is up 0.87% at $34.63 at publication Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44353699/niu-q4-rides-high-on-demand-for-e-scooters-but-gross-margins-decline-amid-higher-costs" target="_blank" rel="noreferrer noopener">Niu Q4 Rides High On Demand For E-Scooters, But Gross Margins Decline Amid Higher Costs</a></li>
</ul>
Photo: Shutterstock

Health Care

Movers

Trading Ideas

SRRK

Scholar Rock Stock Jumps On Additional Data From Pivotal Trial Of Muscular Dystrophy Treatment

Tradeweb Markets Inc's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TW#NASDAQ">TW</a>) industry leading organic growth is likely to continue, despite tough comps, according to Goldman Sachs.
The Tradeweb Markets Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/586cf16a351b9b0001a3055a/alexander-blostein">Analyst Alexander Blostein</a> reaffirmed a Buy rating, while raising the price target from $145 to $152.
The Tradeweb Markets Thesis: The company is likely to generate mid-teen revenue growth through 2027, Blostein said in the note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Rates is likely to account for 60% of the company's revenue growth over the next several years, he added.
"We see higher industry volumes amid rising Treasury issuance and increased activity down the curve supporting a 10%-12% growth backdrop for industry volumes, with TW's share gain opportunities and positive mix shift, particularly in Swaps (much faster growth in Risk trades vs. Compression trades, duration extension and EM) driving above-consensus revenue growth for this business," the analyst wrote.
Although Credit, which is Tradeweb Markets' second-largest business, is likely to face heightened competition over time, the flagship Portfolio Trading offering "is proving out to be more resilient than perceived," which could support further share gains, he further stated.
Price Action: Shares of Tradeweb Markets had risen by 3.18% to $140.12 at the time of publication on Monday.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/insights/analyst-ratings/25/02/43568843/forecasting-the-future-6-analyst-projections-for-tradeweb-markets">Forecasting The Future: 6 Analyst Projections For Tradeweb Markets</a></li>
</ul>
Image: Shutterstock

Analyst Color

Reiteration

This Tradeweb Markets Analyst Remains Bullish About Organic Growth, Raises Forecast

Economics

Markets

ACWI

SPDR Dow Jones Industrial Average ETF Trust

The Number Of People Working Part-Time Jobs While Seeking Full-Time Employment Jumped 460,000 In February, To 4.9 Million, The Highest Since May 2021.

<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="1024" height="768" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/17132939/image-2.png" alt="" class="wp-image-8061" style="width:436px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/17132939/image-2.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/17132939/image-2-300x225.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/17132939/image-2-768x576.png 768w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Real estate has always been a favored investment avenue, providing stability and long-term growth. However, when it comes to investing in real estate, investors face a crucial decision: should they invest in Real Estate Investment Trusts (REITs) or directly purchase physical properties? Both options have their pros and cons, and choosing the right approach depends on one's financial goals, risk tolerance, and investment strategy.
<h2 class="wp-block-heading">Why Consider REITs?</h2>
REITs offer investors exposure to real estate without the complexities of owning and managing physical properties. Here are three key advantages:
Lower Entry Barrier – Unlike purchasing a property that requires a significant upfront investment, REITs allow investors to enter the real estate market with relatively small amounts of capital. With share prices often below $100, investors can diversify across multiple real estate sectors without large capital commitments.
High Liquidity – Selling a physical property can take months, whereas REITs trade on stock exchanges, allowing investors to buy and sell shares almost instantly. This liquidity makes REITs more flexible compared to direct real estate investments.
Tax Efficiency – Buying and managing rental properties can be tax-heavy, with property taxes, capital gains taxes, and maintenance costs. REITs, on the other hand, are structured as securities, meaning investors are taxed on dividends rather than facing the full tax burden associated with property ownership.
<ol>
<li></li>
</ol>
<h2 class="wp-block-heading">Why Buy Physical Properties?</h2>
For those looking for tangible assets and direct control, buying physical properties remains a strong option. Here's why some investors prefer it:
<ol>
<li>Stable Income and Appreciation – Rental properties generate steady income through rent payments while appreciating over time, providing a dual benefit.</li>
<li>Leverage Opportunities – Investors can use mortgages to acquire real estate with less upfront capital, potentially increasing returns if property values rise.</li>
<li>Tax Benefits – Property owners can take advantage of tax deductions, including mortgage interest, depreciation, and maintenance expenses, which can reduce taxable income.</li>
</ol>
<h2 class="wp-block-heading">Some REITs to Consider</h2>
For those interested in REITs, selecting the right fund is essential. Below are some top-performing REIT ETFs that provide diverse real estate exposure:
<ul>
<li>iShares Core U.S. REIT ETF (<a href="https://www.ishares.com/us/products/239544/ishares-core-us-real-estate-etf">USRT</a>) – Tracks the U.S. real estate market across retail, healthcare, industrial, and residential properties. Offers a diversified portfolio with an expense ratio of just 0.08%.</li>
<li>JPMorgan BetaBuilders (<a href="https://am.jpmorgan.com/us/en/asset-management/adv/products/jpmorgan-betabuilders-msci-us-reit-etf-etf-shares-46641q738">BBRE</a>) – Provides exposure to large, mid, and small-cap U.S. REITs, with a slightly higher SEC yield at 3.78%.</li>
<li>SPDR Dow Jones REIT ETF (<a href="https://www.ssga.com/us/en/intermediary/etfs/spdr-dow-jones-reit-etf-rwr">RWR</a>) – Concentrated in retail and residential REITs, with a moderate expense ratio of 0.25% and strong yield.</li>
</ul>
<h2 class="wp-block-heading">So, what do we end up with?</h2>
Both REITs and physical real estate have their place in a well-diversified portfolio. REITs offer accessibility, liquidity, and tax efficiency, that makes them attractive for passive investors. On the other hand, direct property investments provide control, leverage, and long-term appreciation potential. The best choice depends on an investor's goals, risk tolerance, and investment horizon. Regardless of the path chosen, real estate remains a cornerstone of wealth-building strategies.

Equities

REIT

Sector ETFs

Opinion

Personal Finance

ETFs

Real Estate

Real Estate Investing: REITs Vs. Physical Properties; 3 ETFs To Consider

Global

Sustainable Style: How AI Is Reducing Waste In The Fashion World

CL King analyst David Silver upgrades nVent Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVT#NYSE">NVT</a>) from Neutral to Buy and announces $70 price target.

Upgrades

CL King Upgrades nVent Electric to Buy, Announces $70 Price Target

Brokerage Robinhood Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) is launching more event contracts after its successful launch of<a href="https://www.benzinga.com/general/sports-betting/24/11/41719799/robinhood-passes-100-million-2024-election-contracts-do-users-favor-trump-or-harris-on-sto"> 2024 election contracts for users.</a>
What Happened: On Monday, Robinhood announced it is launching event contracts for every match-up and the championship for the NCAA Men's College Basketball and NCAA Women's College Basketball Tournaments.
The news follows Robinhood's previously announced partnership with prediction market Kalshi, which is regulated by the Commodity Futures Trading Commission. Robinhood previously planned to launch Super Bowl event contracts before <a href="https://www.benzinga.com/general/sports-betting/25/02/43482999/robinhood-ends-super-bowl-lix-bets-plan-after-cftc-complaint">pulling out after concerns</a> from the CFTC.
The new contracts will be <a href="https://go.robinhood.com/collegebasketball">available </a>to U.S. Robinhood users during the trading hours of 8 a.m. ET to 3 a.m. ET.
"Now you can trade on the outcome of every match-up in the men's and women's college basketball tournaments, including the final championships," Robinhood said.
The contracts have costs in cents and will cash out at $1 if the team wins or $0 if they lose. Users can also cash out of their positions at any time before the match-up is over.
"The Robinhood engineering team was working in lockstep with us to ensure a smooth launch at market open. We did it with elections and now we will do it for sports, together we will change the world of finance and trading. Welcome to the show, Robinhood," Kalshi CEO Tarek Mansour tweeted.
Read Also: <a href="https://www.benzinga.com/news/earnings/25/02/43676276/robinhood-q4-earnings-highlights-record-revenue-eps-beat-analyst-estimates-crypto-revenue-up-700">Robinhood Q4 Earnings Highlights: Record Revenue, EPS Beat Analyst Estimates, Crypto Revenue Up 700%+</a>
Why It's Important: The launch of the March Madness events contracts continues Robinhood's push into regulated sports betting with Kalshi.
Robinhood CEO Vlad Tenev recently <a href="https://www.benzinga.com/markets/equities/25/02/43683255/robinhood-ceo-vlad-tenev-says-prediction-markets-are-the-future-amid-super-bowl-lix-suspension-and-missing-regulatory-clarity">highlighted the future potential </a>of events contracts after the success of hundreds of millions of 2024 election contracts traded.
"Prediction markets are the future, not just as an active trading asset, but also news and information," Tenev said.
Robinhood will collect a commission of $0.01 per contract. While this seems minimal, it could add up quickly if hundreds of millions of contracts are traded during the March Madness tournaments.
For sportsbooks like DraftKings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) and Flutter Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLUT#NYSE">FLUT</a>), which own FanDuel, Robinhood's new event contracts could reduce their market share during the tournament.
HOOD Price Action: Robinhood stock is up 5.5% to $41.42 on Monday versus a 52-week trading range of $13.98 to $66.08. Robinhood stock is up 4.3% year-to-date in 2025 and up 125.9% over the last year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/sports-betting/23/03/31371508/march-madness-perfect-bracket-odds-hold-my-beer-mega-millions-and-powerball">March Madness Perfect Bracket Odds </a></li>
</ul>
Photo: Shutterstock

Sports Betting

Sports

DKNG

FLUT

HOOD

Robinhood Launches March Madness Event Contracts With Kalshi: 'Change The World Of Finance And Trading'

Piper Sandler analyst Alexander Goldfarb maintains Innovative Ind Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>) with a Underweight and lowers the price target from $70 to $60.

IIPR

Piper Sandler Maintains Underweight on Innovative Ind Props, Lowers Price Target to $60

Whales with a lot of money to spend have taken a noticeably bullish stance on Vistra.
Looking at options history for Vistra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) we detected 23 trades.
If we consider the specifics of each trade, it is accurate to state that 47% of the investors opened trades with bullish expectations and 39% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $546,542 and 17, calls, for a total amount of $646,324.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $80.0 to $165.0 for Vistra over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Vistra stands at 355.0, with a total volume reaching 897.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Vistra, situated within the strike price corridor from $80.0 to $165.0, throughout the last 30 days.
<h3>Vistra Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742228167_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>VST</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$39.0</td>
<td>$39.0</td>
<td>$39.0</td>
<td>$165.00</td>
<td>$195.0K</td>
<td>505</td>
<td align="right">50</td>
</tr>
<tr>
<td>VST</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$17.8</td>
<td>$17.7</td>
<td>$17.8</td>
<td>$135.00</td>
<td>$178.0K</td>
<td>350</td>
<td align="right">105</td>
</tr>
<tr>
<td>VST</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$32.3</td>
<td>$29.45</td>
<td>$30.57</td>
<td>$160.00</td>
<td>$91.5K</td>
<td>120</td>
<td align="right">30</td>
</tr>
<tr>
<td>VST</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$25.5</td>
<td>$24.25</td>
<td>$25.2</td>
<td>$140.00</td>
<td>$78.1K</td>
<td>1.5K</td>
<td align="right">53</td>
</tr>
<tr>
<td>VST</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$35.7</td>
<td>$34.85</td>
<td>$34.85</td>
<td>$155.00</td>
<td>$69.7K</td>
<td>71</td>
<td align="right">30</td>
</tr>
</tbody>
</table>

<h3>About Vistra</h3>
Vistra Energy is one of the largest power producers and retail energy providers in the us Following the 2024 Energy Harbor acquisition, Vistra owns 41 gigawatts of nuclear, coal, natural gas, and solar power generation along with one of the largest utility-scale battery projects in the world. Its retail electricity business serves 5 million customers in 20 states, including almost a third of all Texas electricity consumers. Vistra emerged from the Energy Future Holdings bankruptcy as a stand-alone entity in 2016. It acquired Dynegy in 2018.
<h3>Present Market Standing of Vistra</h3>
<ul>
<li>Currently trading with a volume of 2,803,940, the VST's price is up by 3.03%, now at $128.23. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 51 days.</li>
</ul>
<h3>Professional Analyst Ratings for Vistra</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $152.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from B of A Securities has elevated its stance to Buy, setting a new price target at $152. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Vistra, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Check Out What Whales Are Doing With VST

Investors with a lot of money to spend have taken a bearish stance on IonQ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with IONQ, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 10 options trades for IonQ.
This isn't normal.
The overall sentiment of these big-money traders is split between 20% bullish and 80%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $28,500, and 9, calls, for a total amount of $315,984.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $15.0 to $25.0 for IonQ during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for IonQ options trades today is 937.86 with a total volume of 3,992.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for IonQ's big money trades within a strike price range of $15.0 to $25.0 over the last 30 days.
<h3>IonQ Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742228162_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>IONQ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$16.0</td>
<td>$15.8</td>
<td>$15.8</td>
<td>$15.00</td>
<td>$47.4K</td>
<td>1.0K</td>
<td>31</td>
</tr>
<tr>
<td>IONQ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/28/25</td>
<td>$4.3</td>
<td>$4.15</td>
<td>$4.2</td>
<td>$22.00</td>
<td>$42.0K</td>
<td>515</td>
<td>100</td>
</tr>
<tr>
<td>IONQ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/25/25</td>
<td>$6.1</td>
<td>$5.9</td>
<td>$6.1</td>
<td>$21.00</td>
<td>$38.4K</td>
<td>37</td>
<td>129</td>
</tr>
<tr>
<td>IONQ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$2.21</td>
<td>$1.91</td>
<td>$1.91</td>
<td>$25.00</td>
<td>$38.2K</td>
<td>3.9K</td>
<td>1.6K</td>
</tr>
<tr>
<td>IONQ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/25/25</td>
<td>$6.0</td>
<td>$5.8</td>
<td>$5.8</td>
<td>$21.00</td>
<td>$36.5K</td>
<td>37</td>
<td>3</td>
</tr>
</tbody>
</table>

<h3>About IonQ</h3>
IonQ Inc sells access to several quantum computers of various qubit capacities and is in the process of researching and developing technologies for quantum computers with increasing computational capabilities. The company currently makes access to its quantum computers available via cloud platforms and also to select customers via its own cloud service. This cloud-based approach enables the broad availability of quantum-computing-as-a-service (QCaaS). The company derives its revenue from its quantum-computing-as-a-service arrangements, consulting services related to co-developing algorithms on company's quantum computing systems and contracts associated with the design, development, and construction of specialized quantum computing systems together with related services.
In light of the recent options history for IonQ, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>IonQ's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 18,920,136, the IONQ's price is down by -1.92%, now at $24.52. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 51 days.</li>
</ul>
<h3>Professional Analyst Ratings for IonQ</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $49.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Benchmark has decided to maintain their Buy rating on IonQ, which currently sits at a price target of $45. 
&#x2A; An analyst from Needham downgraded its action to Buy with a price target of $54. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for IonQ with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

IONQ

A Closer Look at IonQ's Options Market Dynamics

Investors with a lot of money to spend have taken a bullish stance on Archer Aviation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ACHR, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 11 uncommon options trades for Archer Aviation.
This isn't normal.
The overall sentiment of these big-money traders is split between 63% bullish and 36%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $103,786, and 9 are calls, for a total amount of $550,730.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $4.0 to $20.0 for Archer Aviation during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Archer Aviation options trades today is 9204.38 with a total volume of 2,436.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Archer Aviation's big money trades within a strike price range of $4.0 to $20.0 over the last 30 days.
<h3>Archer Aviation Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742228157_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ACHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$3.4</td>
<td>$2.65</td>
<td>$2.67</td>
<td>$12.00</td>
<td>$267.0K</td>
<td>3.6K</td>
<td align="right">0</td>
</tr>
<tr>
<td>ACHR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$4.4</td>
<td>$4.25</td>
<td>$4.4</td>
<td>$10.00</td>
<td>$75.6K</td>
<td>974</td>
<td align="right">11</td>
</tr>
<tr>
<td>ACHR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$5.6</td>
<td>$5.5</td>
<td>$5.5</td>
<td>$4.00</td>
<td>$49.5K</td>
<td>3.7K</td>
<td align="right">90</td>
</tr>
<tr>
<td>ACHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$1.91</td>
<td>$1.72</td>
<td>$1.91</td>
<td>$20.00</td>
<td>$38.2K</td>
<td>4.8K</td>
<td align="right">898</td>
</tr>
<tr>
<td>ACHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$1.8</td>
<td>$1.67</td>
<td>$1.8</td>
<td>$20.00</td>
<td>$36.0K</td>
<td>4.8K</td>
<td align="right">403</td>
</tr>
</tbody>
</table>

<h3>About Archer Aviation</h3>
Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a fully electric vertical takeoff and landing eVTOL aircraft for use in UAM networks. It is creating an electric airline that moves people throughout cities in a quick, safe, sustainable, and cost-effective manner.
Following our analysis of the options activities associated with Archer Aviation, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Archer Aviation</h3>
<ul>
<li>With a volume of 17,407,793, the price of ACHR is up 2.53% at $8.1. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 52 days.</li>
</ul>
<h3>Expert Opinions on Archer Aviation</h3>
A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $12.75.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Needham persists with their Buy rating on Archer Aviation, maintaining a target price of $13. 
&#x2A; An analyst from Canaccord Genuity persists with their Buy rating on Archer Aviation, maintaining a target price of $13. 
&#x2A; An analyst from Raymond James persists with their Outperform rating on Archer Aviation, maintaining a target price of $12. 
&#x2A; In a cautious move, an analyst from HC Wainwright &amp; Co. downgraded its rating to Buy, setting a price target of $12. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Archer Aviation options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

ACHR

Market Whales and Their Recent Bets on ACHR Options

JP Morgan analyst Philip Cusick maintains Crown Castle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCI#NYSE">CCI</a>) with a Neutral and lowers the price target from $121 to $115.

JP Morgan Maintains Neutral on Crown Castle, Lowers Price Target to $115

WIIM

AMTX

Aemetis shares are trading higher after Ascendiant Capital maintained a Buy rating on the stock and raised its price target from $18 to $19.

Jefferies analyst Lloyd Byrne maintains Civitas Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIVI#NYSE">CIVI</a>) with a Buy and lowers the price target from $73 to $48.

CIVI

Jefferies Maintains Buy on Civitas Resources, Lowers Price Target to $48

CRWD

CrowdStrike shares are trading higher. The stock may be moving higher after NTT DATA announced it expanded its partnership with the company to strengthen its cybersecurity services.

Keefe, Bruyette &amp; Woods analyst Tim Switzer reiterates Atlanticus Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATLC#NASDAQ">ATLC</a>) with a Market Perform and raises the price target from $45 to $52.

ATLC

Keefe, Bruyette & Woods Reiterates Market Perform on Atlanticus Holdings, Raises Price Target to $52

Press Releases

UTime Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Contracts

UTime Limited Partners with Dr. Ehud Baron to Pioneer AI-Driven Health Solutions

UTime Limited Announces Ambitious AI Health Strategy and Strategic Collaboration

UTime Limited to Participate in International Medical Fairs and Medical Conferences

About Circul VS: A Core Continuous Blood Pressure Measurement Technology System Developed in Partnership with Dr. Ehud Baron

UTime Signs NDA to Acquire Monkeypox Vaccine Maker Bowen Therapeutics Inc and Supports Completion of FDA Registration of Related Vaccines

Remarkable Announcement on Significant Fluctuation of the UTime's Share Price

UTime Limited Announces 1-For-25 Reverse Share Split

UTime Limited Announces Pricing of $5 Million Registered Direct Offering

UTime Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency

Comments

UTime

UTime (WTO) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL